Clinical-High-Risk for Mixed Psychosis: Early Phase of Schizoaffective Disorder?


Bora İ. E., Yalınçetin B., Uzman Özbek S., Süt E., Akdede B. B.

2025 Annual Congress of Schizophrenia International Research Society, Illinois, Amerika Birleşik Devletleri, 29 Mart - 02 Nisan 2025, ss.11, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Illinois
  • Basıldığı Ülke: Amerika Birleşik Devletleri
  • Sayfa Sayıları: ss.11
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background: Clinical-High-Risk for psychosis (CHR-P) is an important concept in identifying the potential prodromal phase of psychotic disorder. CHR-P is associated with significant functional impairment and cognitive deficits. Recently, a smaller number of studies investigated clinical-high-risk for bipolar disorder (CHR-BD). However, unlike chronic stages, the early phase of schizoaffective disorders has not been the focus of available studies. In this study, we aimed the characteristics of investigate at-risk subjects who meet the criteria of both CHR-P and CHR-BD (CHR-Mixed Psychoses (CHR-MP)) compared to at-risk subjects meeting only one of these high-risk states.

Methods: This study included 89 youth with CHR-P, 65 with CHR-BD and 36 CHR-MP. Structured clinical interviews for at risk for psychosis and bipolar disorder, the Personal and Social Performance Scale and a comprehensive battery including processing speed, verbal memory, visual memory, working memory, executive functions, attention and social cognition were administered to all participants.

Results: There were significant differences for clinical, social functioning, neurocognition and social cognition between groups. CHR-MP had more negative symptoms, social functional and neurocognitive impairment compared to CHR-BD. Neurocognitive differences were particularly significant for verbal memory (p < 0.001) and processing speed (p < 0.001). In general, the cognitive profile of CHR-MP was intermediate between CHR-BD and CHR-P. At follow-up, UHR-MP was associated with conversion to both first-episode psychosis (FEP) and first-episode bipolar disorder (FEBD). In contrast, CHR-BD and CHR-P groups did only convert to expected diagnoses (CHR-BD to FEBD and CHR-P to FEP).

Discussion: The clinical, functional and cognitive profile of CHR-MP lies between CHR-P and CHR-BD. CHR-MP might be the early stage of schizoaffective disorder and related mixed psychotic-affective presentations. Follow-up studies are needed to establish long-term prognosis of cases CHR-MP.